A


Resource | v1 | created by semantic-scholar-bot |
Type Paper
Created 2012-01-01
Identifier DOI: 10.1515/9783111548050-012

Description

The CDI Enhanced COVID-19 Test is a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acid from SARSCoV-2 in nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate nasal swabs as well as nasopharyngeal wash/aspirate or nasal aspirate specimens from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to the Hackensack University Medical Center (HUMC) Molecular Pathology Laboratory located in Hackensack, NJ which is a Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, certified high-complexity laboratory.

Relations

Edit details Edit relations Attach new author Attach new topic Attach new resource
0.0 /10
useless alright awesome
from 0 reviews
Write comment Rate resource Tip: Rating is anonymous unless you also write a comment.
Resource level 0.0 /10
beginner intermediate advanced
Resource clarity 0.0 /10
hardly clear sometimes unclear perfectly clear
Reviewer's background 0.0 /10
none basics intermediate advanced expert
Comments 0
Currently, there aren't any comments.